| Hazard Information | Back Directory | [Description]
CDK9-IN-9 is a potent and selective CDK9 inhibitor that has has anti-cancer activity. | [Uses]
CDK9-IN-9 (example 2) is a potent and selective CDK9 inhibitor with an IC50 of 1.8 nM. CDK9-IN-9 inhibits CDK2 with an IC50 of 155 nM. CDK9-IN-9 has anti-cancer activity[1]. | [IC 50]
CDK9: 1.8 nM (IC50); CDK2: 155 nM (IC50) | [References]
[1] Ulrich LüCKING, et al. Novel ptefb inhibiting macrocyclic compounds. WO2018177889A1. |
|
| Company Name: |
BOC Sciences
|
| Tel: |
1-631-485-4226; 16314854226 |
| Website: |
https://www.bocsci.com |
| Company Name: |
cjbscvictory
|
| Tel: |
13348960310 13348960310 |
| Website: |
www.weikeqi-biotech.com/ |
|